Haematologica (Mar 2024)
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
- Emilio Iannitto,
- Simone Ferrero,
- Côme Bommier,
- Daniela Drandi,
- Martina Ferrante,
- Krimo Bouabdallah,
- Sylvain Carras,
- Guido Gini,
- Vincent Camus,
- Salvatrice Mancuso,
- Luigi Marcheselli,
- Angela Ferrari,
- Michele Merli,
- Benoit Tessoulin,
- Caterina Stelitano,
- Kheira Beldjord,
- Giovanni Roti,
- Fabrice Jardin,
- Barbara Castagnari,
- Francesca Palombi,
- Lucile Baseggio,
- Alexandra Traverse-Glehen,
- Claudio Tripodo,
- Anna Marina Liberati,
- Margherita Parolini,
- Sara Usai,
- Caterina Patti,
- Massimo Federico,
- Maurizio Musso,
- Marco Ladetto,
- Emanuele Zucca,
- Catherine Thieblemont
Affiliations
- Emilio Iannitto
- La Maddalena Department of Oncology, Onco-Hematology and Bone Marrow Transplantation Unit, Palemo, Italy; Tumor Immunology Unit Department of Health Sciences University of Palermo School of Medicine. Istituto di Patologia Generale, Palermo
- Simone Ferrero
- Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino
- Côme Bommier
- Universitè Paris Citè; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris
- Daniela Drandi
- Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino
- Martina Ferrante
- Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino
- Krimo Bouabdallah
- CHU de Bordeaux - Hôpital Haut Lèvêque and Centre François Magendie, Service d'Hématologie Clinique et Thérapie Cellulaire, Pessac
- Sylvain Carras
- Univ. Grenoble Alpes. Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309). University Hospital, Molecular Biology and Hematology departments, Grenoble
- Guido Gini
- Ematologia AOU delle Marche, Ancona
- Vincent Camus
- Department of Hematology, Centre Henri Becquerel, Rouen
- Salvatrice Mancuso
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Hematology Unit, University of Palermo
- Luigi Marcheselli
- Fondazione Italiana Linfomi ETS, Modena
- Angela Ferrari
- Azienda Unità Sanitaria Locale-IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia
- Michele Merli
- Hematology, Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, Varese
- Benoit Tessoulin
- Nantes University Hospital and CRC2 NA, Nantes
- Caterina Stelitano
- UO Ematologia AO Bianchi-Melacrino-Morelli, Reggio Calabria
- Kheira Beldjord
- Universitè Paris Citè
- Giovanni Roti
- Dipartimento di Medicina e Chirurgia, Università di Parma, AOU di Parma
- Fabrice Jardin
- Ematologia AOU delle Marche, Ancona
- Barbara Castagnari
- Department of Hematology, Ravenna hospital, Ravenna
- Francesca Palombi
- Hematology Unit, IRCCS Regina Elena National Cancer Institute, Roma
- Lucile Baseggio
- Laboratoire d'Hèmatologie Biologique, Groupement Hospitalier Lyon-Sud/Hospices Civils de Lyon
- Alexandra Traverse-Glehen
- Service d'Anatomie Pathologique, Groupement Hospitalier Lyon-Sud/Hospices Civils de Lyon
- Claudio Tripodo
- Tumor Immunology Unit Department of Health Sciences University of Palermo School of Medicine. Istituto di Patologia Generale, Palermo
- Anna Marina Liberati
- Oncohematology Unit, University of Perugia, Azienda Ospedaliera S.Maria, Terni
- Margherita Parolini
- Ematologia Istituto Romagnolo Per Lo studio dei Tumori Dino Amadori, Meldola
- Sara Usai
- Ospedale Oncologico A. Businco, Cagliari
- Caterina Patti
- U.O.C. di Oncoematologia Ospedali Riuniti Villa Sofia - Cervello, Palermo
- Massimo Federico
- CHIMOMO dept. University of Modena and Reggio Emilia
- Maurizio Musso
- La Maddalena Department of Oncology, Onco-Hematology and Bone Marrow Transplantation Unit, Palemo
- Marco Ladetto
- University of Eastern Piedmont Amedeo Avogadro S.S. Antonio and Biagio and Cesaro Arrigo Hospital, Alessandria
- Emanuele Zucca
- IOSI, Oncology Institute of Southern Switzerland and IOR: Institute of Oncology Research IELSG International Extranodal Lymphoma Study, Bellinzona, Switzerland
- Catherine Thieblemont
- Universitè Paris Citè; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris
- DOI
- https://doi.org/10.3324/haematol.2023.284109
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
